Seventeen patients with disseminated cancer were treated with a human leukocyte interferon preparation in doses ranging from 3 X zzso to 50 X zzso IU daily for 30 zzso Doses above 18 X zzso IU were considered zzso in this schedule of administration due to severe fatigue and weight zzso Serum concentrations of interferon were lower than those achieved with either partially pure native or recombinant leukocyte zzso Three of 17 patients in this study showed minimal evidence of tumor zzso Two patients treated at doses of 18 X zzso 36 X zzso and 50 X zzso IU also received a 5 X zzso dose of a second human leukocyte interferon zzso The latter resulted in less toxicity but similar serum zzso These results suggest that human leukocyte interferons prepared in the same manner may differ significantly in their in vivo biologic zzso 
